Delivery Order SPE2DB20D1109-SPE2DB25FP02P

Award Date 5/7/25
Potential Completion Date 5/8/25
Potential Value $6.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,507.44, is for the delivery of 4560843381 - Telmisartan-HCTZ 80-12.5 mg tablets in units of 30s. The contract has a firm fixed price and has a completion date of May 8, 2023. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,431.30, is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets. It is a firm fixed-price contract with a completion date of February 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count units, with a ceiling value of $6,560.81 and a completion date of June 21, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,851.03, is for the provision of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count unit doses. The award was made on January 7, 2025, with an ultimate completion date of January 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 80-25 mg tablets, a medication used to treat hypertension. The contract is a firm fixed-price delivery order with a ceiling value of $10,006.35 and a period of performance through July 15, 2024. The contract was not set aside for any specific business...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,173.42 and is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and has no major subcontractors...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,926.81, is for the delivery of Telmisartan-HCTZ 80-25 mg tablets. It has an ultimate completion date of March 6, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a $4,330.99 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,966.87, is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 10, 2025. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,960.02, is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count units. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FP02P
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,553.64, is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count units. The contract is a firm fixed-price delivery order, with a period of performance through May 8, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, providing a comprehensive global pharmaceutical support vehicle through December 2026. Through this IDC, Amerisourcebergen supplies a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other government agencies.

Generated 8/6/25, 9:50 AM